Eton Pharmaceuticals Inc (ETON) Annual Income Statement (USD)
ETON Quarterly Financials (USD)
Frequently Asked Questions About Eton Pharmaceuticals Inc (ETON) Stock
Eton Pharmaceuticals Inc's (ETON) last reported annual revenue was USD 31.64 Million.
Eton Pharmaceuticals Inc's (ETON) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Eton Pharmaceuticals Inc's(ETON) is not profitable as of its last reported annual financials.
The net profit margin for Eton Pharmaceuticals Inc's(ETON) from its laster reported year is -2.96%
The return on equity (ROE) for Eton Pharmaceuticals Inc's(ETON) from its last reported annual financials is : -6.56%
The return on assets (ROA) for Eton Pharmaceuticals Inc's(ETON) from its last reported annual financials is : -2.63%
The return on invested capital (ROIC) for Eton Pharmaceuticals Inc's(ETON) from its last reported annual financials is : -5.91%
The Debt to Equity ratio for Eton Pharmaceuticals Inc's(ETON) from its last reported annual financials is : 0.00%
The dividend yield for Eton Pharmaceuticals Inc's(ETON) from its laster reported year is 0.00%
Eton Pharmaceuticals Inc's(ETON) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ETON !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
